CAPRICOR THERAPEUTICS, INC. Accumulated Amortization, Debt Issuance Costs
CAPRICOR THERAPEUTICS, INC. (CAPR) had Accumulated Amortization, Debt Issuance Costs of $8.56 thousand as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Notes › Debt
us-gaap:AccumulatedAmortizationDeferredFinanceCosts · last filed 2014-05-15
- 2014-03-31: Accumulated Amortization, Debt Issuance Costs $8.56K.
- 2013-12-31: Accumulated Amortization, Debt Issuance Costs $6.72K.
- 2012-12-31: Accumulated Amortization, Debt Issuance Costs $0.00.
| Period end | Accumulated Amortization, Debt Issuance Costs |
|---|---|
| 2014-03-31 | $8.56K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $6.72K 10-Q · filed 2014-05-15 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |